Overview of pancreatic stenting and its complications

INTRODUCTION

Pancreatic endotherapy has been increasingly used for the treatment of a variety of pancreatic disorders including chronic pancreatitis, idiopathic acute recurrent pancreatitis, pancreatic duct leaks or disruptions, drainage of pseudocysts, and the prevention of pancreatitis following endoscopic retrograde cholangiopancreatography (ERCP).

One of the most common types of pancreatic endotherapy is pancreatic stenting. Stenting of the main pancreatic duct has been used to relieve ductal obstruction, often in the setting of refractory pain from strictures, stones, or papillary stenosis. In addition, stenting of the minor papilla has been used in the treatment of symptomatic pancreas divisum secondary to a stenotic minor papilla [1]. The indications, efficacy and complications related to pancreatic stents will be reviewed here. The role of pancreatic stents to prevent ERCP-induced pancreatitis is discussed in detail separately. (See "Prophylactic pancreatic stents to prevent ERCP-induced pancreatitis: When do you use them?".)

INSTRUMENTS AND TECHNIQUES

A variety of guidewires, dilators, and stents are available. The choice of instruments will depend upon the clinical setting.

Guidewires — Guidewires vary in diameter (0.018", 0.021", 0.025", and 0.035") and length, and may be hydrophilic, straight, have a "J" tip, or a loop tip. They are available with various radiopaque markings to minimize fluoroscopy time. Some guidewires are Teflon-coated, which provides the greatest stability for stent placement and accessory exchanges. Electrically insulated wires can be left in place during sphincterotomy. Glidewire and "Roadrunner" are special wires used for difficult cannulation and access at ERCP.

Dilators — Two types of dilators are most commonly used: balloon dilators and dilating catheters. Balloon dilators are inflation devices housed on a catheter, which are used to deliver a specific pressure to a strictured or stenosed area. They are available in several diameters and lengths. An inflation device is required to pressurize the balloon at a controlled rate.

                          

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Sep 2014. | This topic last updated: Jun 6, 2014.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2014 UpToDate, Inc.
References
Top
  1. Elta GH. Temporary prophylactic pancreatic stents: which patients need them? Gastrointest Endosc 2008; 67:262.
  2. Somogyi L, Chuttani R, Croffie J, et al. Biliary and pancreatic stents. Gastrointest Endosc 2006; 63:910.
  3. Rashdan A, Fogel EL, McHenry L Jr, et al. Improved stent characteristics for prophylaxis of post-ERCP pancreatitis. Clin Gastroenterol Hepatol 2004; 2:322.
  4. Afghani E, Akshintala VS, Khashab MA, et al. 5-Fr vs. 3-Fr pancreatic stents for the prevention of post-ERCP pancreatitis in high-risk patients: a systematic review and network meta-analysis. Endoscopy 2014; 46:573.
  5. Lawrence C, Cotton PB, Romagnuolo J, et al. Small prophylactic pancreatic duct stents: an assessment of spontaneous passage and stent-induced ductal abnormalities. Endoscopy 2007; 39:1082.
  6. Abdel Aziz, AM, Mchenry L, Fogel EL, et al. 3 Fr prophylactic pancreatic stent: What is the optimal stent length?. Gastrointest Endosc 2008; 67:AB326.
  7. Drake DH, Fry WJ. Ductal drainage for chronic pancreatitis. Surgery 1989; 105:131.
  8. Bradley EL 3rd. Pancreatic duct pressure in chronic pancreatitis. Am J Surg 1982; 144:313.
  9. Dumonceau JM, Devière J, Le Moine O, et al. Endoscopic pancreatic drainage in chronic pancreatitis associated with ductal stones: long-term results. Gastrointest Endosc 1996; 43:547.
  10. Karanjia ND, Singh SM, Widdison AL, et al. Pancreatic ductal and interstitial pressures in cats with chronic pancreatitis. Dig Dis Sci 1992; 37:268.
  11. Laugier R. Dynamic endoscopic manometry of the response to secretin in patients with chronic pancreatitis. Endoscopy 1994; 26:222.
  12. Devière J, Delhaye M, Cremer M. Pancreatic duct stones management. Gastrointest Endosc Clin N Am 1998; 8:163.
  13. Delhaye M, Vandermeeren A, Baize M, Cremer M. Extracorporeal shock-wave lithotripsy of pancreatic calculi. Gastroenterology 1992; 102:610.
  14. Sauerbruch T, Holl J, Sackmann M, Paumgartner G. Extracorporeal lithotripsy of pancreatic stones in patients with chronic pancreatitis and pain: a prospective follow up study. Gut 1992; 33:969.
  15. Tandan M, Reddy DN, Santosh D, et al. Extracorporeal shock wave lithotripsy and endotherapy for pancreatic calculi-a large single center experience. Indian J Gastroenterol 2010; 29:143.
  16. Sherman S, Lehman GA, Hawes RH, et al. Pancreatic ductal stones: frequency of successful endoscopic removal and improvement in symptoms. Gastrointest Endosc 1991; 37:511.
  17. Huibregtse K, Schneider B, Vrij AA, Tytgat GN. Endoscopic pancreatic drainage in chronic pancreatitis. Gastrointest Endosc 1988; 34:9.
  18. Nealon WH, Townsend CM Jr, Thompson JC. Operative drainage of the pancreatic duct delays functional impairment in patients with chronic pancreatitis. A prospective analysis. Ann Surg 1988; 208:321.
  19. Smits ME, Rauws EA, Tytgat GN, Huibregtse K. Endoscopic treatment of pancreatic stones in patients with chronic pancreatitis. Gastrointest Endosc 1996; 43:556.
  20. Barthet M, Sahel J, Bodiou-Bertei C, Bernard JP. Endoscopic transpapillary drainage of pancreatic pseudocysts. Gastrointest Endosc 1995; 42:208.
  21. Catalano MF, Geenen JE, Schmalz MJ, et al. Treatment of pancreatic pseudocysts with ductal communication by transpapillary pancreatic duct endoprosthesis. Gastrointest Endosc 1995; 42:214.
  22. Ponchon T, Bory RM, Hedelius F, et al. Endoscopic stenting for pain relief in chronic pancreatitis: results of a standardized protocol. Gastrointest Endosc 1995; 42:452.
  23. Smits ME, Badiga SM, Rauws EA, et al. Long-term results of pancreatic stents in chronic pancreatitis. Gastrointest Endosc 1995; 42:461.
  24. Cremer M, Devière J, Delhaye M, et al. Stenting in severe chronic pancreatitis: results of medium-term follow-up in seventy-six patients. Endoscopy 1991; 23:171.
  25. Binmoeller KF, Jue P, Seifert H, et al. Endoscopic pancreatic stent drainage in chronic pancreatitis and a dominant stricture: long-term results. Endoscopy 1995; 27:638.
  26. Devière J, Bueso H, Baize M, et al. Complete disruption of the main pancreatic duct: endoscopic management. Gastrointest Endosc 1995; 42:445.
  27. Kozarek RA, Ball TJ, Patterson DJ, et al. Transpapillary stenting for pancreaticocutaneous fistulas. J Gastrointest Surg 1997; 1:357.
  28. Kozarek RA, Jiranek GC, Traverso LW. Endoscopic treatment of pancreatic ascites. Am J Surg 1994; 168:223.
  29. Bracher GA, Manocha AP, DeBanto JR, et al. Endoscopic pancreatic duct stenting to treat pancreatic ascites. Gastrointest Endosc 1999; 49:710.
  30. Kozarek RA, Traverso LW. Endoscopic treatment of chronic pancreatitis: An alternative to surgery?. Dig Surg 1996; 13:90.
  31. Wolfsen HC, Kozarek RA, Ball TJ, et al. Pancreaticoenteric fistula: no longer a surgical disease? J Clin Gastroenterol 1992; 14:117.
  32. Catalano MF, Lahoti S, Alcocer E, et al. Dynamic imaging of the pancreas using real-time endoscopic ultrasonography with secretin stimulation. Gastrointest Endosc 1998; 48:580.
  33. Lans JI, Geenen JE, Johanson JF, Hogan WJ. Endoscopic therapy in patients with pancreas divisum and acute pancreatitis: a prospective, randomized, controlled clinical trial. Gastrointest Endosc 1992; 38:430.
  34. Ertan A. Long-term results after endoscopic pancreatic stent placement without pancreatic papillotomy in acute recurrent pancreatitis due to pancreas divisum. Gastrointest Endosc 2000; 52:9.
  35. Heyries L, Barthet M, Delvasto C, et al. Long-term results of endoscopic management of pancreas divisum with recurrent acute pancreatitis. Gastrointest Endosc 2002; 55:376.
  36. Sherman S, Alvarez C, Robert M, et al. Polyethylene pancreatic duct stent-induced changes in the normal dog pancreas. Gastrointest Endosc 1993; 39:658.
  37. Tarnasky P, Cunningham J, Cotton P, et al. Pancreatic sphincter hypertension increases the risk of post-ERCP pancreatitis. Endoscopy 1997; 29:252.
  38. Geenen JE, Rolny P. Endoscopic therapy of acute and chronic pancreatitis. Gastrointest Endosc 1991; 37:377.
  39. Ashby K, Lo SK. The role of pancreatic stenting in obstructive ductal disorders other than pancreas divisum. Gastrointest Endosc 1995; 42:306.
  40. Freeman ML, Overby C, Qi D. Pancreatic stent insertion: consequences of failure and results of a modified technique to maximize success. Gastrointest Endosc 2004; 59:8.
  41. Bakman YG, Safdar K, Freeman ML. Significant clinical implications of prophylactic pancreatic stent placement in previously normal pancreatic ducts. Endoscopy 2009; 41:1095.
  42. Kozarek RA. Pancreatic stents can induce ductal changes consistent with chronic pancreatitis. Gastrointest Endosc 1990; 36:93.
  43. Morgan DE, Smith JK, Hawkins K, Wilcox CM. Endoscopic stent therapy in advanced chronic pancreatitis: relationships between ductal changes, clinical response, and stent patency. Am J Gastroenterol 2003; 98:821.
  44. Smith MT, Sherman S, Ikenberry SO, et al. Alterations in pancreatic ductal morphology following polyethylene pancreatic stent therapy. Gastrointest Endosc 1996; 44:268.
  45. Ikenberry SO, Sherman S, Hawes RH, et al. The occlusion rate of pancreatic stents. Gastrointest Endosc 1994; 40:611.
  46. Buscaglia JM, DiMaio CJ, Pollack MJ, et al. Are large side holes associated with reduced rates of pancreatic stent occlusion? Results of a prospective study. JOP 2009; 10:496.
  47. Provansal-Cheylan M, Bernard JP, Mariani A, et al. Occluded pancreatic endoprostheses--analysis of the clogging material. Endoscopy 1989; 21:63.
  48. Johanson JF, Schmalz MJ, Geenen JE. Incidence and risk factors for biliary and pancreatic stent migration. Gastrointest Endosc 1992; 38:341.
  49. Shapiro AM, Scudamore CH, July LV, et al. Calcific intra-pancreatic embedding of a pancreatic stent necessitating surgical removal--a danger of chronic endoscopic retrograde pancreatic stent placement. Gastrointest Endosc 1999; 50:860.
  50. Heyries L, Desjeux A, Sahel J. Bile duct-duodenum and pancreatic-gastric fistulas: two exceptional complications of biliary and pancreatic stenting. Gastrointest Endosc 1999; 50:571.
  51. Lahoti S, Catalano MF, Geenen JE, Schmalz MJ. Endoscopic retrieval of proximally migrated biliary and pancreatic stents: experience of a large referral center. Gastrointest Endosc 1998; 47:486.
  52. Sherman S, Hawes RH, Savides TJ, et al. Stent-induced pancreatic ductal and parenchymal changes: correlation of endoscopic ultrasound with ERCP. Gastrointest Endosc 1996; 44:276.
  53. Johanson JF, Schmalz MJ, Geenen JE. Simple modification of a pancreatic duct stent to prevent proximal migration. Gastrointest Endosc 1993; 39:62.
  54. Howell D, Bernadino K, Ansari A, et al. Refined technique of pancreatic duct endoscopic sphincterotomy (PDES) produces results comparable to biliary sphincterotomy: an eight year cohort study. Gastrointest Endosc 2005; 61:AB191.
  55. Elton E, Howell DA, Parsons WG, et al. Endoscopic pancreatic sphincterotomy: indications, outcome, and a safe stentless technique. Gastrointest Endosc 1998; 47:240.